GLP-1 drugs

GLP-1 drugs, initially developed for diabetes treatment, have gained widespread use for obesity management and are significantly reshaping US healthcare. Recent research indicates these drugs may also offer therapeutic benefits for hormonal disorders such as Premature Ovarian Insufficiency Syndrome (PMOS). Beyond promoting weight loss, studies suggest GLP-1s can improve insulin resistance, hormone balance, and ovulation in individuals with PMOS, offering new hope for those affected. This expanding application highlights the growing versatility and impact of GLP-1 medications, moving them beyond their original indications and underscoring their current relevance in addressing diverse health challenges.